Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Page Properties
idtag

Author

  • David Pasquarelli

  • Michael Bellefountaine

Publisher

  • San Francisco Chronicle

Category

  • Activism

Topic

  • Dissident Movement

  • Protease Inhibitors

  • Pharmaceutical industry

Article Type

  • News ArticleColumn

Publish Year

  • 2000

Page Properties
idmeta

Meta Description

  • The article discusses the criticism of AIDS treatments by dissidents who believe the drugs and science behind them are profit-driven and harmful to patients.

Summary

  • The article discusses the actions and beliefs of a group called ACT-UP, which aimed to speed up the introduction of AIDS drugs. The group questioned the effectiveness and safety of these drugs, believing that they caused harm rather than providing a cure. They criticized the medical establishment for labeling individuals with AIDS as expendable and argued against the rushed approval process for new drugs. The article highlights the adverse effects of protease inhibitors, a class of drugs used to treat AIDS, and the growing list of activists who died from the drugs they fought for. The article concludes by acknowledging the mistakes made by ACT-UP and the need to make amends for the damage caused.

Meta Tag

  • AIDS

  • Dissidents

  • Drugs

  • Science

  • Profit

  • ACT-UP

  • Protease inhibitors

  • Experimental treatments

  • Adverse effects

  • FDA (Food and Drug Administration)

  • Activism

  • Pharmaceutical industry

Featured Image

Featured Image Alt Tag

  • Keyword of the image

...